BOI Stock Overview
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Boiron SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €34.30 |
| 52 Week High | €56.50 |
| 52 Week Low | €32.48 |
| Beta | 0.47 |
| 1 Month Change | 3.88% |
| 3 Month Change | -16.67% |
| 1 Year Change | -11.02% |
| 3 Year Change | -15.52% |
| 5 Year Change | -25.43% |
| Change since IPO | 642.11% |
Recent News & Updates
Recent updates
Calculating The Intrinsic Value Of Boiron SA (EPA:BOI)
Jan 26
Boiron (EPA:BOI) Has Re-Affirmed Its Dividend Of €0.95
Apr 28Estimating The Intrinsic Value Of Boiron SA (EPA:BOI)
Jan 22Is Boiron SA's (EPA:BOI) 2.3% Dividend Worth Your Time?
Apr 30Boiron (EPA:BOI) Has A Pretty Healthy Balance Sheet
Apr 12Reflecting on Boiron's (EPA:BOI) Share Price Returns Over The Last Three Years
Mar 08A Look At The Intrinsic Value Of Boiron SA (EPA:BOI)
Feb 18
Does The Market Have A Low Tolerance For Boiron SA's (EPA:BOI) Mixed Fundamentals?
Feb 02Should You Buy Boiron SA (EPA:BOI) For Its Dividend?
Jan 19Does Boiron's (EPA:BOI) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 27What Kind Of Shareholders Hold The Majority In Boiron SA's (EPA:BOI) Shares?
Dec 14Shareholder Returns
| BOI | FR Pharmaceuticals | FR Market | |
|---|---|---|---|
| 7D | 1.8% | 6.9% | -0.2% |
| 1Y | -11.0% | -9.0% | 2.4% |
Return vs Industry: BOI exceeded the French Pharmaceuticals industry which returned -12.8% over the past year.
Return vs Market: BOI underperformed the French Market which returned 4% over the past year.
Price Volatility
| BOI volatility | |
|---|---|
| BOI Average Weekly Movement | 3.7% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in FR Market | 9.2% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: BOI has not had significant price volatility in the past 3 months.
Volatility Over Time: BOI's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1932 | 2,813 | Valérie Lorentz-Poinsot | www.boiron.fr |
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain.
Boiron SA Fundamentals Summary
| BOI fundamental statistics | |
|---|---|
| Market cap | €595.52m |
| Earnings (TTM) | €47.62m |
| Revenue (TTM) | €517.36m |
12.5x
P/E Ratio1.2x
P/S RatioIs BOI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BOI income statement (TTM) | |
|---|---|
| Revenue | €517.36m |
| Cost of Revenue | €135.11m |
| Gross Profit | €382.25m |
| Other Expenses | €334.63m |
| Earnings | €47.62m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Sep 11, 2024
| Earnings per share (EPS) | 2.74 |
| Gross Margin | 73.88% |
| Net Profit Margin | 9.20% |
| Debt/Equity Ratio | 0.5% |
How did BOI perform over the long term?
See historical performance and comparisonDividends
3.2%
Current Dividend Yield40%
Payout RatioDoes BOI pay a reliable dividends?
See BOI dividend history and benchmarks| Boiron dividend dates | |
|---|---|
| Ex Dividend Date | Jun 03 2024 |
| Dividend Pay Date | Jun 05 2024 |
| Days until Ex dividend | 38 days |
| Days until Dividend pay date | 40 days |
Does BOI pay a reliable dividends?
See BOI dividend history and benchmarks